Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : ATIS is on the move! -- Ignore unavailable to you. Want to Upgrade?

To: D. Noss who wrote (1792)	4/13/1999 10:46:00 PM
From: Marshall Teitelbaum	Respond to of 2205

DN, Many reasons for the large volume, but churning ultimately occurred, as big fundamental news with that type of volume would have gone well above the low 3s. ORG has been discussed in much detail over the years here...I'd suggest looking up ORG, LIFC, IART, GZTC, ORTC, and ATIS to look at the bulk of the main tissue engineer early stage guys, come up with some opinions based on what you see, and discuss from there. There are some similarities, but far more differences between org and atis. marshall